Healthtech pioneer DrFirst has announced further investment which takes its fundraising in the past year to $135million.
The business works with almost 300,000 healthcare professionals, including more than 100,000 prescribers, nearly half of the electronic health record (EHR) systems in the US, and more than 1,400 hospitals in the US and Canada.
DrFirst was founded in 2000 to tackle some of the most challenging issues in healthcare, starting with e-prescribing and progressing to its current portfolio of solutions, which encompasses telehealth as part of care collaboration and patented artificial intelligence (AI) that improves the accuracy of patient medication history.
Its sustained business growth, long-standing work with leading health systems, expanding customer base and proven leadership in the digital health solutions market underscore the investments.
In addition to its investment, Lee Mooney of Sixth Street has joined DrFirst’s Board of Directors.
“The follow-on investment from Sixth Street Growth signals their deep commitment to DrFirst as we continue to bring practical, collaborative tools to market that solve daily problems among healthcare stakeholders, including clinicians, patients, hospitals, ambulatory practices, pharmacies, and payers,” says James F Chen, founder and CEO of DrFirst.
“We’re also thrilled to have Sixth Street join our Board as an innovation-minded partner that understands the value and impact of secure information sharing in improving patient outcomes.”
Sixth Street Growth, which has a dedicated team focused on partnering with growing healthcare technology companies, is making its second investment in DrFirst in seven months.
“Software that improves healthcare workflows has been a long-term theme for our team, and DrFirst stands out as a scaled and differentiated enterprise technology platform providing high-quality, user-friendly technology solutions,” says Michael McGinn, partner and co-head of Sixth Street Growth.
“Their offerings help physicians provide better, more informed care, which ultimately accrues to the benefit of patients and all healthcare stakeholders.”